ThirdAge

SEGA Tumors Respond to mTOR Inhibitor
MedPage Today
SEGA tumors are a common consequence of tuberous sclerosis, a genetic disease affecting an estimated one to two million people worldwide. "This study, which included SEGA patients from infancy to adulthood, provides compelling evidence of the impact of ...
Novartis' Afinitor reduces SEGA tumour sizeReuters
Novartis' Afinitor drug meets primary goal of phase 3 trial for TSC drugProactive Investors USA & Canada
Tuberous Sclerosis Complex-Related Tumors Reduced By Afinitor DrugThirdAge
FiercePharma -RTT News -PR Newswire (press release)
all 35 news articles »


More...